Can I take ashwagandha with semaglutide?

The decision: what actually changes when semaglutide enters the picture

Semaglutide slows the rate at which your stomach empties its contents into the small intestine. For prescription medicines, this is clinically significant because it can shift the timing of absorption, which is exactly why, for example, oral contraceptives need additional back-up during tirzepatide treatment. Supplements are less studied in this context, but the same gastric-emptying mechanism applies. An ashwagandha capsule taken at the same time as breakfast may simply sit in the stomach longer before being broken down.

This is not necessarily dangerous, but it is worth being aware of. If you take ashwagandha for sleep or anxiety management, a shift in absorption timing might subtly alter when you notice its effects. If you take it to support athletic recovery, the practical impact is probably negligible. Either way, the gap between 'pharmacokinetically uneventful' and 'worth mentioning to your prescriber' is narrower with a GLP-1 medicine than with most other treatments.

If you are working through the basics of who can start Wegovy in the first place, the overview on who semaglutide is suitable for covers the licensed criteria in full.

Ashwagandha's blood-glucose effects and why they matter on semaglutide

Several small clinical studies have found that ashwagandha supplementation modestly lowers fasting blood glucose and HbA1c in people with stress-related metabolic changes or prediabetes. Semaglutide also reduces blood glucose, that is one of the reasons it is licensed for type 2 diabetes as well as weight management. In most people on Wegovy for weight management without diabetes, this dual glucose-lowering effect is unlikely to cause symptomatic hypoglycaemia, because semaglutide's mechanism is glucose-dependent (it works harder when blood sugar is high and backs off when it is normal).

The nuance matters most if you have prediabetes, are monitoring your glucose closely, or are on any additional medicines that affect blood sugar. In those circumstances, adding an adaptogen with documented glucose effects is a conversation to have before you open the packet, not after.

There is also evidence that ashwagandha suppresses cortisol. Chronically elevated cortisol is linked to weight gain and insulin resistance, so in theory reducing it sits comfortably alongside the goals of a weight-management programme. In practice, the magnitude of ashwagandha's cortisol effect in healthy adults is modest. It is unlikely to disrupt your treatment, but 'unlikely' is not a green light to take a supplement without checking in.

What your prescriber needs to know (and when to ask

A common question our prescribers hear is roughly: 'I started taking ashwagandha a few months before Wegovy) do I need to stop?' The short answer is that you do not need to stop immediately, but you do need to disclose it. Every consultation at nume involves a clinician reading your full medical and medication history, including supplements. That review happens before your prescription is issued, and again before each repeat, a real clinician, not an automated check.

If you have already ordered and are curious about other supplements or over-the-counter medicines in a similar vein, the guidance on taking naproxen with semaglutide illustrates how the prescriber's logic works for drugs where the interaction profile is better characterised.

Timing your consultation is also practical: if you are planning a course of ashwagandha (say, starting it in January alongside a New Year health push, or picking it up on payday) flag it at your next clinical review rather than assuming the supplement aisle advice covers you.

For a broader look at Wegovy itself, the Wegovy overview page covers the treatment in full, including eligibility and what to expect from the titration schedule.

The bottom line before you decide

Nothing in the current evidence base makes ashwagandha a flat contraindication alongside semaglutide. The NHS semaglutide page does not list it. However, three things give reason for a brief pause: semaglutide's gastric-emptying effect changes how supplements absorb; ashwagandha has modest but real blood-glucose activity; and supplements as a category are chronically under-disclosed to prescribers, which is where avoidable problems start.

The right course is to list ashwagandha on your consultation form, let a prescriber consider it alongside your other health details, and carry on if they are comfortable. If you are still working out whether you meet the criteria to start treatment, reading up on how BMI is used to assess semaglutide eligibility is a sensible next step, and if you are close to the lower threshold, the detail on whether a BMI of 25 qualifies you for semaglutide is worth reviewing before your consultation, as is the guidance on whether a BMI of 26 qualifies you for semaglutide if you sit just above that point.

Ready to have your full picture reviewed? Check your eligibility with our prescribers, the consultation is free and handled the same day.